One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study

Bente Glintborg; Inge Juul Sørensen; E Omerovic; F Mehnert; N Manilo; Kamilla  Danebod; Dorte Vendelbo Jensen; Henrik  Nordin; O Hendricks; A G  Loft; S Chrysidis; B L Andersen; J L  Raun; H Lindegaard; J Espesen; S H Jakobsen; I J  Hansen; E B Dalgaard; D D Pedersen; S Kristensen; A  Linauskas; L S Andersen; J Grydehøj; N S Krogh; Merete Lund Hetland

One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study

Bente Glintborg, Inge Juul Sørensen, E Omerovic, F Mehnert, N Manilo, Kamilla Danebod, Dorte Vendelbo Jensen, Henrik Nordin, O Hendricks, A G Loft, S Chrysidis, B L Andersen, J L Raun, H Lindegaard, J Espesen, S H Jakobsen, I J Hansen, E B Dalgaard, D D Pedersen, S KristensenA Linauskas, L S Andersen, J Grydehøj, N S Krogh, Merete Lund Hetland

Department for Rheumatology and Spine Diseases

Original language	English
Article number	PP66
Book series	Scandinavian Journal of Rheumatology, Supplement
Volume	47
Issue number	Suppl. 129
Pages (from-to)	56-7
Number of pages	2
ISSN	0301-3847
Publication status	Published - 2018

Cite this

Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Hendricks, O., Loft, A. G., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. J., Dalgaard, E. B., Pedersen, D. D., ... Hetland, M. L. (2018). One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study. Scandinavian Journal of Rheumatology, Supplement, 47(Suppl. 129), 56-7. Article PP66.

One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study. / Glintborg, Bente ; Sørensen, Inge Juul; Omerovic, E et al.
In: Scandinavian Journal of Rheumatology, Supplement, Vol. 47, No. Suppl. 129, PP66, 2018, p. 56-7.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B , Sørensen, IJ, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K , Jensen, DV, Nordin, H, Hendricks, O, Loft, AG, Chrysidis, S, Andersen, BL, Raun, JL, Lindegaard, H, Espesen, J, Jakobsen, SH, Hansen, IJ, Dalgaard, EB, Pedersen, DD, Kristensen, S, Linauskas, A, Andersen, LS, Grydehøj, J, Krogh, NS & Hetland, ML 2018, 'One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study', Scandinavian Journal of Rheumatology, Supplement, vol. 47, no. Suppl. 129, PP66, pp. 56-7.

Glintborg B , Sørensen IJ, Omerovic E, Mehnert F, Manilo N, Danebod K et al. One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study. Scandinavian Journal of Rheumatology, Supplement. 2018;47(Suppl. 129):56-7. PP66.

Glintborg, Bente ; Sørensen, Inge Juul ; Omerovic, E et al. / One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study. In: Scandinavian Journal of Rheumatology, Supplement. 2018 ; Vol. 47, No. Suppl. 129. pp. 56-7.

@article{f2da5e7765214702a0fedb84de5926de,

title = "One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study",

author = "Bente Glintborg and S{\o}rensen, \{Inge Juul\} and E Omerovic and F Mehnert and N Manilo and Kamilla Danebod and Jensen, \{Dorte Vendelbo\} and Henrik Nordin and O Hendricks and Loft, \{A G\} and S Chrysidis and Andersen, \{B L\} and Raun, \{J L\} and H Lindegaard and J Espesen and Jakobsen, \{S H\} and Hansen, \{I J\} and Dalgaard, \{E B\} and Pedersen, \{D D\} and S Kristensen and A Linauskas and Andersen, \{L S\} and J Grydeh{\o}j and Krogh, \{N S\} and Hetland, \{Merete Lund\}",

note = "COPECARE",

year = "2018",

language = "English",

volume = "47",

pages = "56--7",

journal = "Scandinavian Journal of Rheumatology, Supplement",

issn = "0301-3847",

publisher = "Taylor and Francis A.S.",

number = "Suppl. 129",

}

TY - ABST

T1 - One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study

AU - Glintborg, Bente

AU - Sørensen, Inge Juul

AU - Omerovic, E

AU - Mehnert, F

AU - Manilo, N

AU - Danebod, Kamilla

AU - Jensen, Dorte Vendelbo

AU - Nordin, Henrik

AU - Hendricks, O

AU - Loft, A G

AU - Chrysidis, S

AU - Andersen, B L

AU - Raun, J L

AU - Lindegaard, H

AU - Espesen, J

AU - Jakobsen, S H

AU - Hansen, I J

AU - Dalgaard, E B

AU - Pedersen, D D

AU - Kristensen, S

AU - Linauskas, A

AU - Andersen, L S

AU - Grydehøj, J

AU - Krogh, N S

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

SN - 0301-3847

VL - 47

SP - 56

EP - 57

JO - Scandinavian Journal of Rheumatology, Supplement

JF - Scandinavian Journal of Rheumatology, Supplement

IS - Suppl. 129

M1 - PP66

ER -